System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gil Y Melmed is an expert in Gastroenterology at Cedars-Sinai Medical Center (United States). As of July 2026, ScienceLeadR ranks Gil Y Melmed in the top 1% of experts worldwide for Crohn Disease, Gastroenteritis and Inflammatory Bowel Diseases. Gil Y Melmed has authored 571 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 1 of them ongoing. SLR score: 3,103 (community average: 125). How the SLR is computed.

LeadR Profile

Gil Y Melmed Cedars-Sinai Medical Center United States
3 103 ScienceLeadR Reputation 3103

Unlock

Register Login
Network Map

Gastroenterology

Subspecialties: Public Health - Pharmacy - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2026
Source: PubMed

Cedars-Sinai Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 571

Citations

Citations: 15 783 1st author: 50 Last author: 145 Unique author: 6

Main journals

Gastroenterology 221
Am J Gastroenterol 88
Inflamm Bowel Dis 67
J Crohns Colitis 24
Clin Gastroenterol Hepatol 20

Best Journals

Gastroenterology 13
N Engl J Med 4
Ann Intern Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitis.
PMID 42376682 — colitis, crohn disease, network meta-analysis, therapeutics, colitis, ulcerative		Crohns Colitis 36020262
Upfront medical or surgical treatment in Crohn's disease.
PMID 42269626 — liver diseases, crohn disease, therapeutics, gastrointestinal diseases		Lancet Gastroenterol Hepatol Top journal20260
Ultrasound criteria for transmural healing and response in Crohn's disease: a systematic review of definitions and thresholds.
PMID 42222916 — crohn disease, inflammatory bowel diseases, colitis, ulcerative		Inflamm Bowel Dis20260
Real-World Implementation of Treat to Target in Patients With IBD in a Learning Health System: An IBD Qorus Collaborative Study.
PMID 41500500 — crohn disease, inflammatory bowel diseases, learning, quality improvement, colitis, ulcerative		Inflamm Bowel Dis20260
Intestinal Ultrasound for Monitoring Postoperative Crohn's Disease: A Review and Visual Atlas.
PMID 41335492 — crohn disease, inflammatory bowel diseases, colitis, ulcerative		Inflamm Bowel Dis20250

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 7
Phase 3 4
Phase 2 2
Early Phase 1 1
Phase 4 1

By status:

Completed 10
Terminated 4
Recruiting 1

By type:

Interventional 14
Observational 1

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 8

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Treat to Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173 — colitis, crohn disease, insurance, therapeutics, colitis, ulcerative, clinical trials as topic, pragmatic clinical trials as topic		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS